2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
54
Neoplasms
38
Lung Neoplasms
24
Colorectal Neoplasms
24
Prostatic Neoplasms
17
Uterine Cervical Neoplasms
14
Motor Activity
13
Colonic Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Rectal Neoplasms
9
Pancreatic Neoplasms
9
Hematologic Neoplasms
9
Anxiety Disorders
9
Urinary Bladder Neoplasms
8
Obesity
8
Melanoma
8
Lymphoma
8
Depression
8
Ovarian Neoplasms
7
Endometrial Neoplasms
7
Vulvar Neoplasms
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Breast Carcinoma In Situ
6
Sarcoma
5
Papillomavirus Infections
5
Pain
5
Leukemia, Myeloid, Acute
5
Hematopoietic and Lymphatic System Neoplasm
5
Triple Negative Breast Neoplasms
4
Interventions
Tea
1
Surveys and Questionnaires
1
Propofol
1
Midazolam
1
Methods
1
Fluorodeoxyglucose F18
1
Fentanyl
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Respiration Disorders
×
Methods
×
Clear all
NCT03750110
2022-05-19
YESS
University of Nottingham
Phase NA
Completed
1,001 enrolled